"Anti-Bacterial Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances that inhibit the growth or reproduction of BACTERIA.
| Descriptor ID |
D000900
|
| MeSH Number(s) |
D27.505.954.122.085
|
| Concept/Terms |
Anti-Bacterial Agents- Anti-Bacterial Agents
- Agents, Anti-Bacterial
- Anti Bacterial Agents
- Antibacterial Agents
- Agents, Antibacterial
- Anti-Bacterial Compounds
- Anti Bacterial Compounds
- Compounds, Anti-Bacterial
Anti-Mycobacterial Agents- Anti-Mycobacterial Agents
- Agents, Anti-Mycobacterial
- Anti Mycobacterial Agents
- Antimycobacterial Agents
- Agents, Antimycobacterial
|
Below are MeSH descriptors whose meaning is more general than "Anti-Bacterial Agents".
Below are MeSH descriptors whose meaning is more specific than "Anti-Bacterial Agents".
This graph shows the total number of publications written about "Anti-Bacterial Agents" by people in this website by year, and whether "Anti-Bacterial Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 2 | 3 |
| 1996 | 3 | 5 | 8 |
| 1997 | 1 | 3 | 4 |
| 1998 | 3 | 4 | 7 |
| 1999 | 1 | 0 | 1 |
| 2000 | 2 | 2 | 4 |
| 2001 | 1 | 2 | 3 |
| 2002 | 1 | 2 | 3 |
| 2003 | 2 | 1 | 3 |
| 2004 | 5 | 3 | 8 |
| 2005 | 4 | 3 | 7 |
| 2006 | 6 | 3 | 9 |
| 2007 | 12 | 5 | 17 |
| 2008 | 6 | 2 | 8 |
| 2009 | 8 | 6 | 14 |
| 2010 | 5 | 5 | 10 |
| 2011 | 6 | 4 | 10 |
| 2012 | 8 | 1 | 9 |
| 2013 | 8 | 13 | 21 |
| 2014 | 9 | 9 | 18 |
| 2015 | 5 | 7 | 12 |
| 2016 | 8 | 14 | 22 |
| 2017 | 13 | 6 | 19 |
| 2018 | 19 | 3 | 22 |
| 2019 | 14 | 4 | 18 |
| 2020 | 17 | 12 | 29 |
| 2021 | 10 | 18 | 28 |
| 2022 | 2 | 22 | 24 |
| 2023 | 2 | 7 | 9 |
| 2024 | 4 | 4 | 8 |
| 2025 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anti-Bacterial Agents" by people in Profiles.
-
Novel Anti-Microbial/Anti-Inflammatory Combination Improves Clinical Outcome of Bacillus cereus Endophthalmitis. Invest Ophthalmol Vis Sci. 2025 Jan 02; 66(1):39.
-
Synthesis, Characterization and Antimicrobial Activity of Trimethylantimony(V) Biscyanoximates, a New Family of Antimicrobials. Molecules. 2024 Dec 06; 29(23).
-
Long-term perioperative antibiotic prophylaxis after urethral reconstruction does not improve clinical outcomes and increases incidence of MDR organisms. World J Urol. 2024 Nov 26; 42(1):648.
-
Iron(III) Binding Properties of PF1140, a Fungal N-Hydroxypyridone, and Activity against Mycoplasma genitalium. J Nat Prod. 2024 Jul 26; 87(7):1746-1753.
-
Inhibitor of Chromosome Segregation in Pseudomonas aeruginosa from Fungal Extracts. ACS Chem Biol. 2024 Jun 21; 19(6):1387-1396.
-
Perforated Appendicitis in Children: Management, Microbiology, and Antibiotic Stewardship. Paediatr Drugs. 2024 May; 26(3):277-286.
-
Novel antimony-based antimicrobial drug targets membranes of Gram-positive and Gram-negative bacterial pathogens. Microbiol Spectr. 2024 Jun 04; 12(6):e0423423.
-
Signaling through the Salmonella PbgA-LapB regulatory complex activates LpxC proteolysis and limits lipopolysaccharide biogenesis during stationary-phase growth. J Bacteriol. 2024 Apr 18; 206(4):e0030823.
-
Desirability of Outcome Ranking and Response Adjusted for Antibiotic Risk (DOOR/RADAR) Post Hoc Analysis Supports Equipoise for Antibiotic Initiation Strategies in Intensive Care Unit-Acquired Pneumonia. Surg Infect (Larchmt). 2024 Apr; 25(3):221-224.
-
The diagnostic dilemma for atypical presentation of progressive human Mpox. BMC Infect Dis. 2023 Dec 05; 23(1):850.